The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse
Open accessAbstract
Nonstandard abbreviations used: systemic lupus erythematosus (SLE); double-stranded DNA (dsDNA); glomerulonephritis (GN); recombinant IL-12 (rIL-12); recombinant IFN-γ (rIFN-γ); concanavalin A (ConA); histone deacetylase (HDAC); histone deacetylase inhibitor (HDI); trichostatin A (TSA); suberonylanilide hydroxamic acid (SAHA); body weight (BW); PBS containing 0.05% Tween (PBS-T); glomerular basement membrane (GBM).including anti-double-stranded DNA (anti-dsDNA) autoantibodies and hypocomplementemia by 12-16 weeks of age; and (c) clinical signs of arthritis, massive lymphadenopathy, splenomegaly, vasculitis, and glomerulonephritis (GN) by the age of 16-24 weeks.Fifty percent of MRL-lpr/lpr mice die by 24 weeks of age, primarily from renal failure (2).Although the etiology of SLE is unknown, a number of key mediators of disease have been identified.Cytokines produced by Th1 and Th2 lymphocytes play a major role in the immunopathogenesis of human and murine SLE (3).Studies of cytokine mRNA and protein in MRLlpr/lpr mice with established disease have documented that splenic Th1 and Th2 subsets are constitutively activated (4).These T cells produce heightened levels of specific cytokines that contribute directly to the aberrant immune response that ultimately leads to dysregulated autoantibody production (3, 4).IFN-γ is a Th1 cytokine that enhances production of IgG2a and IgG3; moreover, this cytokine accelerates GN in both NZB/W F 1 and MRL-lpr/lpr murine models of SLE.In vivo administration of IFN-γ accelerates the disease process, whereas treatment with monoclonal anti-IFN-γ antibody or soluble IFN-γ receptor significantly delays the disease in NZB/W F 1 mice and, to a lesser extent, in MRL-lpr/lpr mice (5, 6). IL-12 is also a Th1 cytokine that promotes differentiation of Th1 CD4 + cells. Administration of IL-12 accelerates GN by promoting intrarenal accumulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Richon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
What's Up and Down with Histone Deacetylation and Transcription?
Pazin, M. J., & Kadonaga, J. T. (1997) · Cell · doi:10.1016/s0092-8674(00)80211-1 · Cited by 821
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Wang, H., Huang, Z.-Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B. D., Briggs, S. D., Allis, C. D., Wong, J., Tempst, P., et al. (2001) · Science · doi:10.1126/science.1060781 · Cited by 805
IκB-β regulates the persistent response in a biphasic activation of NF-κB
Thompson, J. E., Phillips, R. J., Erdjument-Bromage, H., Tempst, P., & Ghosh, S. (1995) · Cell · doi:10.1016/0092-8674(95)90511-1 · Cited by 751
Modulation of Chromatin Structure Regulates Cytokine Gene Expression during T Cell Differentiation
Agarwal, S., & Rao, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80642-1 · Cited by 686
(1996) · Europe PMC (PubMed Central) · Cited by 659
Uncoupling of Immune Complex Formation and Kidney Damage in Autoimmune Glomerulonephritis
Clynes, R., Dumitru, C., & Ravetch, J. V. (1998) · Science · doi:10.1126/science.279.5353.1052 · Cited by 625
Butler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon‐Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2000) · PubMed · Cited by 615
Yang, W.-M., Inouye, C., Zeng, Y., Bearss, D., & Seto, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12845 · Cited by 546
Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., & Howard, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.305 · Cited by 532
Structure of the human immune interferon gene
Gray, P. W., & Goeddel, D. V. (1982) · Nature · doi:10.1038/298859a0 · Cited by 508
Leoni, F., Zaliani, A., Bertolini, G., Porro, G., Pagani, P., Pozzi, P., Donà, G., Fossati, G., Sozzani, S., Azam, T., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052702999 · Cited by 508
Strahl, B. D., Briggs, S. D., Brame, C. J., Caldwell, J. A., Koh, S. S., Ma, H., Cook, R. G., Shabanowitz, J., Hunt, D. F., Stallcup, M. R., et al. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00294-9 · Cited by 453
Vigushin, D. M., Ali, S., Pace, P., Mirsaidi, N., Ito, K., Adcock, I. M., & Coombes, R. C. (2001) · PubMed · Cited by 447
Cloning and expression of murine immune interferon cDNA.
Gray, P. W., & Goeddel, D. V. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.5842 · Cited by 446
Weinberg, J. B., Granger, D. L., Pisetsky, D. S., Seldin, M. F., Misukonis, M. A., Mason, S. N., Pippen, A. M., Ruiz, P., Wood, E. R., & Gilkeson, G. S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.651 · Cited by 435
Self-citationJacob, C. O., van der Meide, P. H., & McDevitt, H. O. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.3.798 · Cited by 386
Turner, B. (1993) · Cell · doi:10.1016/0092-8674(93)90673-e · Cited by 367
Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling
Waltzer, L., & Bienz, M. (1998) · Nature · doi:10.1038/26785 · Cited by 362
Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice.
Balomenos, D., Rumold, R., & Theofilopoulos, A. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci750 · Cited by 356
Watson, M. L., Rao, J. K., Gilkeson, G. S., Ruiz, P., Eicher, E. M., Pisetsky, D. S., Matsuzawa, A., Rochelle, J. M., & Seldin, M. F. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1645 · Cited by 338
Self-citationVidal, M., & Gaber, R. F. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.6317 · Cited by 321
Role of covalent modifications of histones in regulating gene expression
Spencer, V. A., & Davie, J. R. (1999) · Gene · doi:10.1016/s0378-1119(99)00405-9 · Cited by 306
Plevy, S. E., Gemberling, J. H. M., Hsu, S., Dorner, A. J., & Smale, S. T. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4572 · Cited by 302
Activation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors
Magner, W. J., Kazim, A. L., Stewart, C., Romano, M. A., Catalano, G., Grande, C., Keiser, N., Santaniello, F., & Tomasi, T. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7017 · Cited by 294
Chadee, D. N., Hendzel, M. J., Tylipski, C. P., Allis, C. D., Bazett-Jones, D. P., Wright, J. A., & Davie, J. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24914 · Cited by 276
Huang, Y., Doherty, J. J., & Dingledine, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08422.2002 · Cited by 259
Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.
Finck, B. K., Chan, B., & Wofsy, D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117373 · Cited by 235
Cytokines and systemic lupus erythematosus
Dean, G. S., Tyrrell-Price, J., Crawley, E., & Isenberg, D. A. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.4.243 · Cited by 230
In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouse
Murray, L. J., Lee, R., & Martens, C. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200124 · Cited by 215
Watanabe, H., Garnier, G., Circolo, A., Wetsel, R. A., Ruiz, P., Holers, V. M., Boackle, S. A., Colten, H. R., & Gilkeson, G. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.786 · Cited by 207
Self-citationInduction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA.
Gilkeson, G. S., Grudier, J. P., Karounos, D. G., & Pisetsky, D. S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.5.1482 · Cited by 203
Self-citationOzmen, L., Roman, D., Fountoulakis, M., Schmid, G., Ryffel, B., & Garotta, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250103 · Cited by 184
Weinmann, A. S., Plevy, S. E., & Smale, S. T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80141-7 · Cited by 183
Mishra, N., Brown, D. R., Olorenshaw, I. M., & Kammer, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051507098 · Cited by 178
Self-citationFitzpatrick, D. R., Shirley, K. M., McDonald, L. E., Bielefeldt-Ohmann, H., Kay, G. F., & Kelso, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.103 · Cited by 169
Age-associated increase in interleukin 6 in MRL/lpr mice
Tang, B., Matsuda, T., Akira, S., Nagata, N., Ikehara, S., Hirano, T., & Kishimoto, T. (1991) · International Immunology · doi:10.1093/intimm/3.3.273 · Cited by 159
Genes modulated by histone acetylation as new effectors of butyrate activity
Ragione, F. D., Criniti, V., Pietra, V. D., Borriello, A., Oliva, A., Indaco, S., Yamamoto, T., & Zappia, V. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02539-x · Cited by 148
Huang, F., Feng, G. J., Lindop, G. E., Stott, D. I., & Liew, F. Y. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1447 · Cited by 117
Prud’homme, G. J., Kono, D. H., & Theofilopoulos, A. N. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00024-9 · Cited by 116
Histone Deacetylases Augment Cytokine Induction of the iNOS Gene
Yu, Z., Zhang, W., & Kone, B. C. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000024253.59665.f1 · Cited by 111
Koyama, Y., Adachi, M., Sekiya, M., Takekawa, M., & Imai, K. (2000) · Blood · doi:10.1182/blood.v96.4.1490 · Cited by 96
Cloning and structure of the human immune interferon‐gamma chromosomal gene.
Taya, Y., Devos, R., Tavernier, J. H., Cheroutre, H., Engler, G., & Fiers, W. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01277.x · Cited by 90
Nervi, C., Borello, U., Fazi, F., Buffa, V., Pelicci, P. G., & Cossu, G. (2001) · PubMed · Cited by 90
Nüsse, M., Beisker, W., Hoffmann, C., & Tárnok, A. (1990) · Cytometry · doi:10.1002/cyto.990110707 · Cited by 88
Lupus : molecular and cellular pathogenesis
Kammer, G. M., Tsokos, G. C., & Rose, N. R. (1999) · Humana Press eBooks · Cited by 73
Animal Models of Systemic Lupus Erythematosus
Buskila, D., & Shoenfeld, Y. (1994) · Springer eBooks · doi:10.1007/978-94-011-1432-5_9 · Cited by 70
Loss of PU.1 Expression Following Inhibition of Histone Deacetylases
Laribee, R. N., & Klemsz, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5160 · Cited by 65
Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene
Maehara, K., Uekawa, N., & Isobe, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00646-0 · Cited by 46
IGF-II Enhances Trichostatin A-Induced TGFβ1 and p21Waf1,Cip1,Sdi1 Expression in Hep3B Cells
Gray, S. G., Yakovleva, T., Hartmann, W., Tally, M., Bakalkin, G. Y., & Ekström, T. J. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4661 · Cited by 37
Mishra, N., Khan, I. U., Tsokos, G. C., & Kammer, G. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2830 · Cited by 37
Self-citationLymphoid Transcription of the Murine CD21 Gene Is Positively Regulated by Histone Acetylation
Zabel, M. D., Weis, J. J., & Weis, J. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2697 · Cited by 26
Histone deacetylase inhibition results in decreased macrophage CD9 expression
Wang, X., Alfaro, M. L., Evans, G. F., & Zuckerman, S. H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00523-5 · Cited by 20
Cytokines in the Immunopathogenesis of Lupus
Handwerger, B. S., Luzina, I. G., da Silva, L., Storrer, C. E., & Via, C. S. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-703-1_20 · Cited by 20
Koyama, N., Koschmieder, S., Tyagi, S., Nürnberger, H., Wagner, S., Böcker, U., Hoelzer, D. F., Ottmann, O. G., & Kalina, U. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6753 · Cited by 19
Cited by
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,736
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226
Epigenetics in health and disease
Zhang, L., Lu, Q., & Chang, C. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3449-2_1 · Cited by 689
Trained immunity — basic concepts and contributions to immunopathology
Ochando, J., Mulder, W. J. M., Madsen, J. C., Netea, M. G., & Duivenvoorden, R. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00633-5 · Cited by 453
Metadata
- Authors
- Mishra, N., Reilly, C. M., Brown, D. R., Ruiz, P., & Gilkeson, G. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-02-15
- Volume
- 111
- Issue
- 4
- Pages
- 539-552
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2108639843
- Cited by
- 408
- References
- 63
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.